Viewing Study NCT01943461


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2026-01-31 @ 3:27 PM
Study NCT ID: NCT01943461
Status: COMPLETED
Last Update Posted: 2020-09-30
First Post: 2013-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None MSB0010718C View
None anti PD-L1 View
None avelumab View
None Phase 1 View